Alexion Pharmaceuticals, Inc. logo
Alexion Pharmaceuticals, Inc. ALXN

Alexion Pharmaceuticals, Inc. Net Income | ALXN

Net profit is a financial indicator that reflects the remaining amount of money after deducting all expenses and taxes from the company’s total income over a certain period of time. It is one of the key indicators of a company’s financial stability and success.

Net profit is the portion of total profit remaining after taxes and depreciation have been deducted.[1]

It is the result of a company’s operations and reflects its efficiency in managing resources, controlling expenses, and generating income. It includes all operating revenues and expenses, such as sales of goods or services, production costs, administrative expenses, taxes, and other financial metrics.

The calculation of net profit includes the deduction of all necessary expenses such as employee salaries, rent, utilities, taxes, and other mandatory payments. After all these expenses are deducted from the total income, the remaining amount is considered the company’s net profit.

Net profit is an important indicator of a company’s financial health, as it reflects its ability to generate earnings and manage its finances. High net profit indicates business success, competitiveness, and efficiency in resource utilization. It also allows a company to invest in its development, pay dividends to shareholders, or create reserve funds for unforeseen situations.

It serves as a basis for calculating other financial indicators, such as return on sales, return on assets, or return on equity. It is also used to assess the performance of management and make decisions regarding the future development of the company.

However, it should be noted that net profit can be affected by various factors, such as economic conditions, changes in legislation, market competition, and other external influences. Therefore, companies must be prepared for possible changes and take measures to ensure the stability of their financial results.

Annual Net Income Alexion Pharmaceuticals, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
603 M 2.4 B 77.6 M 443 M 399 M 144 M 657 M 253 M 255 M 175 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
2.4 B 77.6 M 541 M

References

  1. Bhamornsiri, S., & Wiggins, C. (2001). Comprehensive income disclosures. The CPA Journal, 71(10), 54.

Net Income of other stocks in the Biotechnology industry

Issuer Net Income Price % 24h Market Cap Country
Aprea Therapeutics Aprea Therapeutics
APRE
-12.6 M $ 0.68 0.16 % $ 4.45 M usaUSA
Aptevo Therapeutics Aptevo Therapeutics
APVO
-26 M $ 1.8 2.27 % $ 568 K usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
-83.8 M $ 4.57 0.44 % $ 489 M usaUSA
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
-65.8 M $ 14.66 12.51 % $ 401 M israelIsrael
Ardelyx Ardelyx
ARDX
-62 M $ 3.39 1.5 % $ 817 M usaUSA
argenx SE argenx SE
ARGX
1.29 B $ 912.87 1.28 % $ 56 B niderlandNiderland
Armata Pharmaceuticals Armata Pharmaceuticals
ARMP
-174 M $ 3.66 3.98 % $ 133 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
-16.1 M $ 25.15 0.04 % $ 3.2 B usaUSA
Artelo Biosciences Artelo Biosciences
ARTL
-12.9 M $ 3.51 0.54 % $ 664 K usaUSA
Arvinas Arvinas
ARVN
-81 M $ 7.46 0.67 % $ 529 M usaUSA
Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals
ARWR
-1.63 M $ 62.35 0.12 % $ 8.34 B usaUSA
Assembly Biosciences Assembly Biosciences
ASMB
-6.12 M $ 22.74 0.89 % $ 255 M usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
-228 M $ 228.03 0.07 % $ 13.8 B danmarkDanmark
Actinium Pharmaceuticals Actinium Pharmaceuticals
ATNM
-33.9 M $ 1.2 2.56 % $ 37.4 M usaUSA
Atossa Therapeutics Atossa Therapeutics
ATOS
-34.8 M $ 2.45 4.7 % $ 21.1 M usaUSA
Atara Biotherapeutics Atara Biotherapeutics
ATRA
32.7 M $ 9.4 1.16 % $ 118 M usaUSA
Aurinia Pharmaceuticals Aurinia Pharmaceuticals
AUPH
287 M $ 15.72 0.49 % $ 2.11 B canadaCanada
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
-288 M $ 1.83 2.81 % $ 487 M britainBritain
Atea Pharmaceuticals Atea Pharmaceuticals
AVIR
-158 M $ 5.13 0.18 % $ 418 M usaUSA
Anavex Life Sciences Corp. Anavex Life Sciences Corp.
AVXL
-46.4 M $ 1.65 0.43 % $ 141 M usaUSA
Axon Enterprise Axon Enterprise
AXON
125 M $ 411.81 0.69 % $ 32.2 B usaUSA
Axsome Therapeutics Axsome Therapeutics
AXSM
-183 M $ 177.08 0.73 % $ 8.81 B usaUSA
Aytu BioScience Aytu BioScience
AYTU
-14.3 M $ 2.04 1.45 % $ 25.1 M usaUSA
BridgeBio Pharma BridgeBio Pharma
BBIO
-733 M $ 66.14 0.51 % $ 12.7 B usaUSA
BioCardia BioCardia
BCDA
-8.23 M $ 1.09 4.81 % $ 7.27 M usaUSA
BioCryst Pharmaceuticals BioCryst Pharmaceuticals
BCRX
264 M $ 8.1 0.31 % $ 1.7 B usaUSA
Bicycle Therapeutics plc Bicycle Therapeutics plc
BCYC
-219 M $ 4.01 18.64 % $ 278 M britainBritain
Black Diamond Therapeutics Black Diamond Therapeutics
BDTX
22.4 B $ 1.94 2.65 % $ 110 M usaUSA
Beam Therapeutics Beam Therapeutics
BEAM
-80 M $ 25.67 4.78 % $ 2.54 B usaUSA
Biogen Biogen
BIIB
1.29 B $ 223.59 1.69 % $ 32.8 B usaUSA
BioVie BioVie
BIVI
-17.5 M $ 1.44 0.68 % $ 2.13 M usaUSA
BioLineRx Ltd. BioLineRx Ltd.
BLRX
-2.03 M $ 2.32 0.43 % $ 5.72 B israelIsrael
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
349 M $ 57.54 0.63 % $ 11 B usaUSA
Bristol-Myers Squibb Company Bristol-Myers Squibb Company
BMY
7.05 B $ 58.81 0.53 % $ 120 B usaUSA
Benitec Biopharma Benitec Biopharma
BNTC
-45.5 M $ 9.23 2.78 % $ 430 M usaUSA
BioNTech SE BioNTech SE
BNTX
-1.14 B $ 97.64 0.76 % $ 23.6 B germanyGermany
Burford Capital Limited Burford Capital Limited
BUR
62.6 M $ 3.55 0.51 % $ 778 M britainBritain
BeyondSpring BeyondSpring
BYSI
-1.01 M $ 0.79 2.12 % $ 32.5 M usaUSA
Cabaletta Bio Cabaletta Bio
CABA
-168 M $ 2.08 4.0 % $ 209 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
-9.83 M $ 2.14 0.45 % $ 3.52 M israelIsrael
Capricor Therapeutics Capricor Therapeutics
CAPR
-105 M $ 7.78 0.11 % $ 362 M usaUSA
Catalyst Biosciences Catalyst Biosciences
CBIO
9.88 M $ 13.94 0.42 % $ 1.25 B usaUSA
C4 Therapeutics C4 Therapeutics
CCCC
-105 M $ 2.99 1.36 % $ 248 M usaUSA
Codexis Codexis
CDXS
-44 M $ 1.39 2.21 % $ 121 M usaUSA
Cerus Corporation Cerus Corporation
CERS
-15.6 M $ 2.34 2.63 % $ 446 M usaUSA
Certara Certara
CERT
-1.6 M $ 10.07 7.59 % $ 1.62 B usaUSA
Cullinan Management Cullinan Management
CGEM
-220 M $ 16.04 3.42 % $ 966 M usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
35.3 M $ 2.31 0.43 % $ 216 M israelIsrael
Coherus BioSciences Coherus BioSciences
CHRS
168 M $ 1.12 0.86 % $ 131 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
-259 M $ 32.59 2.97 % $ 2.16 B usaUSA